Clinical Outcome’s associates at ScHARR (University of Sheffield) will be showcasing their latest research at Virtual ISPOR Europe (16 – 19 November)
11th November 2020
This year’s in-person conference in Milan may have been cancelled, however ScHARR HEDS are excited to be part of the redesigned Virtual ISPOR Europe (16-19 November) to showcase our latest research.
- Dr Nick Latimer will be presenting virtually in two live issue panels: The Meaning of Cure – the Search for What?’ (Monday 16 November) and Is Intention-to-Treat Analysis Still the Gold Standard, or Should All HTA Authorities and Regulators Now Embrace the ICHE(9)R(1) Addendum on Estimands and Sensitivity Analyses? (Thursday 19 November).
- Dr Clara Mukuria will be recording an ‘on demand’ podium presentation, which will be available in the days leading up to the conference through to 31 December. Comparison of the Psychometric Performance of a New Condition-Specific Preference-Based Measure Derived from the Cfq-R (CFQ-R-8D) to EQ-5D-3L and SF-6D to Evaluate Health-Related Quality-of Life (HRQOL) in People with Cystic Fibrosis (CF) is co-authored by Professor John Brazier and Dr Donna Rowen.
Meanwhile, other HEDS colleagues will be presenting virtual posters as part of the online poster programme:
- Dr Laura Gray – BMI Trajectories, Mortality and Comorbidity in Older Adults
- Ben Kearns – Schizophrenia Treatment with Second-Generation Antipsychotics- A MULTI-Country Evaluation of the Costs of Cardiovascular and Metabolic Adverse Events and Weight GAIN
- Tushar Srivastava – Estimation of Transition Probabilities for State-Transition Models – A Review of NICE Appraisals
Visit their exhibitor profile in ISPOR’s virtual exhibits gallery, or contact them ahead of the conference to find out more.
Interact with their virtual profile, and use the Networking and Chat feature to get in touch with their Director of Knowledge Exchange, Suzy Paisley, and Business Manager, Vanessa Wright.
Have a chat with them to find out about the opportunities to work with ScHARR to support key strategic developments in your organisation, to collaborate with them on research and to participate in their diverse, world class learning and teaching programmes.
Find out what else they’ve been up to in their latest HEDS newsletter. Read about their development of COVID related apps, a new UK EQ-5D-5L valuation study, and their recent publications in our Winter 2020 edition.
The Clinical Outcomes team.
Press release sign up
